Subsequent Event - Pending Merger with Laborie Medical Technologies

12 Months Ended

Dec. 31, 2017

Subsequent Event - Pending Merger with Laborie Medical Technologies [Abstract]

Subsequent Event - Pending Merger with Laborie Medical Technologies

Note 12. Subsequent Event – Pending Merger with Laborie Medical Technologies

On March 12, 2018, we entered into a definitive merger agreement (“the Agreement”) with Laborie Medical Technologies (“Laborie”).  Under the Agreement, Laborie will acquire all of the outstanding shares of Cogentix Medical for a total consideration of approximately $239 million.  Under the terms of the Agreement, Laborie, through its wholly-owned subsidiaries LM Parent, Inc., and Camden Merger Sub, Inc. will commence a tender offer for all outstanding shares of Cogentix Medical common stock for $3.85 per share in cash.  The offer of $3.85 per share in cash represents a premium of 28% over the average closing stock price of Cogentix Medical common stock over the last thirty days prior to entering into the agreement.  We anticipate the transaction will close in the first half of the second quarter of 2018.  Upon completion of the transaction, we will become a wholly owned subsidiary of Laborie.